Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
株式のランク
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
株価
$3.89
時価総額
$3.30B
変化（1日）
-3.14%
変化（1年）
43.11%
国
CN
取引 Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
カテゴリー
Healthcare
Guangdong Zhongsheng Pharmaceutical Co., Ltd.（002317）の配当利回りの履歴
Guangdong Zhongsheng Pharmaceutical Co., Ltd.（銘柄コード: 002317）の配当利回り（TTM）は2024-12-31時点で1.69%です。
過去5年間の平均配当利回り: 1.29%
過去5年間の平均配当利回り: 1.29%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.（002317）の2006から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.77% | -28.04% |
| 2025 | 1.07% | -36.69% |
| 2024 | 1.69% | 30.00% |
| 2023 | 1.30% | 75.68% |
| 2022 | 0.74% | -55.42% |
| 2021 | 1.66% | -8.29% |
| 2020 | 1.81% | 15.29% |
| 2019 | 1.57% | -44.91% |
| 2018 | 2.85% | 65.70% |
| 2017 | 1.72% | 56.36% |
| 2016 | 1.10% | -52.38% |
| 2015 | 2.31% | 71.11% |
| 2014 | 1.35% | 6.30% |
| 2013 | 1.27% | -0.78% |
| 2012 | 1.28% | -15.79% |
| 2011 | 1.52% | 102.67% |
| 2010 | 0.75% | 13.64% |
| 2009 | 0.66% | 32.00% |
| 2008 | 0.50% | -20.63% |
| 2007 | 0.63% | 5.00% |
| 2006 | 0.60% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
